Throughout the past two decades, Christine has combined her passion for advancing clinical technology with an entrepreneurial mindset to drive change in getting therapies to patients faster.  Currently serving as the CEO of endpoint Clinical, Christine is proud to be leading a world-class team with a collective vision towards creating seamlessly integrated technology that drives clinical trials forward. Prior to joining endpoint in 2013, Christine worked in a variety of roles in the biotech/pharma industry including a five-year tenure with Takeda Oncology, where she created a team tasked with developing innovative ways to use IRT for clinical supplies logistics as well as forecasting and inventory management. Christine started her IRT career in 2000 as a member of the development team at PAREXEL/Perceptive, she later went on to lead its Product management group.